Scarica l'app Stockscreener
78.08
1.35%
-1.07
Dopo l'orario di chiusura:
78.08
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Forum
Previsione
Frazionamento azionario
Precedente Chiudi:
$79.15
Aprire:
$78.68
Volume 24 ore:
391.85K
Relative Volume:
0.39
Capitalizzazione di mercato:
$2.33B
Reddito:
$442.68M
Utile/perdita netta:
$-77.81M
Rapporto P/E:
-29.26
EPS:
-2.6684
Flusso di cassa netto:
$-28.65M
1 W Prestazione:
+1.30%
1M Prestazione:
+25.07%
6M Prestazione:
-13.39%
1 anno Prestazione:
-36.46%
Intervallo 1D:
$76.98
$79.37
Intervallo di 1 settimana:
$75.58
$83.87
Portata 52W:
$32.21
$170.87
Genedx Holdings Corp Stock (WGS) Company Profile
Nome
Genedx Holdings Corp
Settore
Industria
Telefono
888-729-1206
Indirizzo
333 LUDLOW STREET, STAMFORD
Compare WGS vs TMO, DHR, NTRA, IDXX, A
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
WGS
Genedx Holdings Corp
|
78.08 | 2.46B | 442.68M | -77.81M | -28.65M | -2.6684 |
TMO
Thermo Fisher Scientific Inc
|
588.29 | 222.96B | 45.20B | 6.87B | 6.75B | 18.19 |
DHR
Danaher Corp
|
202.45 | 144.67B | 24.78B | 3.68B | 5.29B | 5.1743 |
NTRA
Natera Inc
|
309.93 | 45.54B | 2.50B | -226.32M | 71.51M | -1.6412 |
IDXX
Idexx Laboratories Inc
|
550.96 | 44.95B | 4.45B | 1.10B | 1.06B | 13.59 |
A
Agilent Technologies Inc
|
148.53 | 41.87B | 7.23B | 1.41B | 1.09B | 4.979 |
Genedx Holdings Corp Stock (WGS) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-02-09 | Aggiornamento | Wells Fargo | Equal Weight → Overweight |
| 2025-10-20 | Iniziato | Canaccord Genuity | Buy |
| 2025-07-09 | Iniziato | Piper Sandler | Overweight |
| 2025-05-15 | Iniziato | Guggenheim | Buy |
| 2025-05-09 | Aggiornamento | Jefferies | Hold → Buy |
| 2024-08-28 | Iniziato | Wells Fargo | Equal Weight |
| 2024-07-10 | Iniziato | Craig Hallum | Buy |
| 2024-06-03 | Ripresa | Jefferies | Hold |
Mostra tutto
Genedx Holdings Corp Borsa (WGS) Ultime notizie
Precision Trading with Genedx Holdings Corp. (WGS) Risk Zones - Stock Traders Daily
The Manufacturers Life Insurance Company Sells 12,820 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
Bronstein, Gewirtz & Grossman, LLC Is Investigating GeneDx Holdings Corp. (WGS) And Encourages Stockholders to Connect - ACCESS Newswire
Sei Investments Co. Trims Stock Position in GeneDx Holdings Corp. $WGS - MarketBeat
WGS INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announce - The National Law Review
Is GeneDx Holdings Corp (WGS) Overvalued After 5.1% Rally? GF Va - GuruFocus
GeneDx Holdings Corp. (WGS) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Stockholders to Contact the Firm to Learn More About the Investigation - ACCESS Newswire
Goldman Sachs Group (WGS) discloses 5.8% beneficial stake in GeneDx Class A - Stock Titan
GeneDx at Canaccord Genuity conference: volume rises, collections lag - Investing.com
GeneDx Holdings (WGS) Is Up 14.8% After Loss-Making Q2, New Capital Raise And Guidance Reaffirmation - simplywall.st
GeneDx launches online exome testing for pediatric patients - Investing.com
GeneDx Lets Families Start Children’s Exome Testing Online - Stock Titan
Assenagon Asset Management S.A. Acquires 208,305 Shares of GeneDx Holdings Corp. $WGS - MarketBeat
GeneDx Holdings Corp (WGS) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
GeneDx Reports Fourth Quarter and Full Year 2025 Financial Results and Reaffirms Guidance for Full Year 2026 - The National Law Review
GeneDx Holdings Corp. $WGS Shares Acquired by Dimensional Fund Advisors LP - MarketBeat
GeneDx (NASDAQ:WGS) Upgraded by Wall Street Zen to Hold Rating - MarketBeat
GeneDx Holdings (WGS) Is Up 18.4% After Reaffirming 2026 Outlook And Raising Equity From Blackstone - Yahoo Finance
WGS CLASS ACTION NOTICE: Faruqi & Faruqi, LLP Reminds GeneDx (WGS - The National Law Review
GeneDx Holdings (WGS): ARK Investment and Cathie Wood report 5.33% ownership - Stock Titan
GeneDx Holdings Corp (WGS) Stock News Today - TradingKey
WGS SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Annou - The National Law Review
GeneDx to Participate in Upcoming Investor Conferences - marketscreener.com
GeneDx Holdings Corp. (NASDAQ:WGS) Analysts Are Pretty Bullish On The Stock After Recent Results - simplywall.st
GeneDx Holdings Corp. Earnings Call Highlights Risks - theglobeandmail.com
GeneDx (WGS) Stock Climbs On Strong Margins As Reimbursement Lags - sahmcapital.com
GeneDx Holdings Corp. (WGS) Options Chain - Yahoo! Finance Canada
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings - Investing.com
Cathie Wood’s ARK sells Palantir stock, buys GeneDx Holdings By Investing.com - Investing.com Nigeria
GeneDx Holdings Corp. Stock 12‑Month Price Target Raised to $85.89, Implies 27% Upside - TradingView
Canaccord Genuity Group Issues Positive Forecast for GeneDx (NASDAQ:WGS) Stock Price - MarketBeat
GeneDx Holdings Corp. Q2 2026 Earnings Call Summary - Yahoo Finance
GeneDx Holdings Corp. (WGS) Stock Analysis: Strong Buy Ratings and 20% Potential Upside - DirectorsTalk Interviews
GeneDx Holdings Corp (WGS) (Q2 2026) Earnings Call Highlights: Record Volume and Early ... By GuruFocus - Investing.com Canada
GeneDx Holdings (WGS) Is Up 9.7% After Beating Q2 Estimates And Reaffirming 2026 OutlookHas The Bull Case Changed? - simplywall.st
GeneDx Q2 Adjusted Earnings Fall, Revenue Rises; Issues Q3 Outlook - Yahoo Finance
GeneDx Holdings Corp. (WGS) Releases Q2 2026 Earnings: Revenue Beats Estimates but Losses Persist - quiverquant.com
CLASS ACTION DEADLINE TONIGHT: Faruqi & Faruqi, LLP Reminds GeneDx (WGS) Investors of Securities Class Action Lawsuit Deadline on August 3, 2026 - Morningstar
Earnings Flash (WGS) GeneDx Holdings Corp. Reports Q2 Revenue $114.4M, vs. FactSet Est of $111.0M - marketscreener.com
GeneDx Reports Q2 2026 Revenue $114.4M, Adjusted Gross Margin ~70%, Reaffirms FY26 Guidance - TradingView
GeneDx Holdings Corp. Q2 2026: Revenue $114.4M, EPS $(0.60) — 10-Q Summary - TradingView
[10-Q] GeneDx Holdings Corp. Quarterly Earnings Report - Stock Titan
GeneDx Holdings (Nasdaq: WGS) grows Q2 2026 revenue to $114.4M amid GAAP loss - Stock Titan
WGS Investors Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit with SBS Law - GlobeNewswire
GeneDx Holdings Corp. $WGS Stock Position Raised by Renaissance Technologies LLC - MarketBeat
GeneDx Holdings Corp. Provides Earnings Guidance for the Third Quarter 2026 and Reaffirms Earnings Guidance for the Full Year 2026 - marketscreener.com
DEADLINE TODAY: GeneDx Holdings Corp. Sued for Securities Law ViolationsContact the DJS Law Group to Discuss Your RightsWGS - Barchart.com
GeneDx Holdings Corp. announced that it expects to receive $4.999987 million in funding - marketscreener.com
WGS Deadline: WGS Investors with Losses in Excess of $100K Have Opportunity to Lead GeneDx Holdings Corp. Securities Fraud Lawsuit - The Avery Journal-Times
WGS DEADLINE MONDAY: ROSEN, TRUSTED INVESTOR COUNSEL, Encourages GeneDx Holdings Corp. ... - Caledonian Record
GENEDX HOLDINGS DEADLINE MONDAY AUGUST 3rd: Bragar Eagel & - GlobeNewswire
Genedx Holdings Corp Azioni (WGS) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.69%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):